VBI Vaccines to Present at the Virus-Like Particle and Nano-Particle Vaccines Conference Biotech Investing
BIND Therapeutics Announces Resignation of Directors Affiliated with Polaris Partners Biotech Investing
UPDATE — Cantabio Pharmaceuticals and University of Antioquia Collaborate to Research Company’s Therapeutic Candidates Targeting DJ-1 Protein to Treat Parkinson’s Disease Biotech Investing
Cascadian Therapeutics Reports Topline ONT-380 "Triplet" Data and Outlines Key Development Strategies Biotech Investing
Marathon Pharmaceuticals Announces Submission of Deflazacort New Drug Application to the FDA Biotech Investing
Great Basin Granted Expanded Patent for Its Highly Sensitive AMPED Molecular Detection Technology Biotech Investing
